|
1
|
Karsa LV, Lignini TA, Patnick J, Lambert R
and Sauvaget C: The dimensions of the CRC problem. Best Pract Res
Clin Gastroenterol. 24:381–396. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zeng H, Zhang S and He J:
Annual report on status of cancer in China, 2011. Chin J Cancer
Res. 27:2–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou M, Zhao H, Wang Z, Cheng L, Yang L,
Shi H, Yang H and Sun J: Identification and validation of potential
prognostic lncRNA biomarkers for predicting survival in patients
with multiple myeloma. J Exp Clin Cancer Res. 34:1022015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
St Laurent G, Wahlestedt C and Kapranov P:
The Landscape of long noncoding RNA classification. Trends Genet.
31:239–251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shang C, Guo Y, Zhang H and Xue YX: Long
noncoding RNA HOTAIR is a prognostic biomarker and inhibits
chemosensitivity to doxorubicin in bladder transitional cell
carcinoma. Cancer Chemother Pharmacol. 77:507–513. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun J, Shi H, Wang Z, Zhang C, Liu L, Wang
L, He W, Hao D, Liu S and Zhou M: Inferring novel lncRNA-disease
associations based on a random walk model of a lncRNA functional
similarity network. Mol Biosyst. 10:2074–2081. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou M, Wang X, Li J, Hao D, Wang Z, Shi
H, Han L, Zhou H and Sun J: Prioritizing candidate disease-related
long non-coding RNAs by walking on the heterogeneous lncRNA and
disease network. Mol Biosyst. 11:760–769. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou M, Xu W, Yue X, Zhao H, Wang Z, Shi
H, Cheng L and Sun J: Relapse-related long non-coding RNA signature
to improve prognosis prediction of lung adenocarcinoma. Oncotarget.
7:29720–29738. 2016.PubMed/NCBI
|
|
10
|
Sun J, Chen X, Wang Z, Guo M, Shi H, Wang
X, Cheng L and Zhou M: A potential prognostic long non-coding RNA
signature to predict metastasis-free survival of breast cancer
patients. Sci Rep. 5:165532015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou M, Zhao H, Xu W, Bao S, Cheng L and
Sun J: Discovery and validation of immune-associated long
non-coding RNA biomarkers associated with clinically molecular
subtype and prognosis in diffuse large B cell lymphoma. Mol Cancer.
16:162017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou M, Zhang Z, Zhao H, Bao S, Cheng L
and Sun J: An immune-related six-lncRNA signature to improve
prognosis prediction of glioblastoma multiforme. Mol Neurobiol.
55:3684–3697. 2017.PubMed/NCBI
|
|
13
|
Morris KV: Long antisense non-coding RNAs
function to direct epigenetic complexes that regulate transcription
in human cells. Epigenetics. 4:296–301. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ricciuti B, Mencaroni C, Paglialunga L,
Paciullo F, Crinò L, Chiari R and Metro G: Long noncoding RNAs: New
insights into non-small cell lung cancer biology, diagnosis and
therapy. Med Oncol. 33:182016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo Q, Cheng Y, Liang T, He Y, Ren C, Sun
L and Zhang G: Comprehensive analysis of lncRNA-mRNA co-expression
patterns identifies immune-associated lncRNA biomarkers in ovarian
cancer malignant progression. Sci Rep. 5:176832015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qiu M, Feng D, Zhang H, Xia W, Xu Y, Wang
J, Dong G, Zhang Y, Yin R and Xu L: Comprehensive analysis of
lncRNA expression profiles and identification of functional lncRNAs
in lung adenocarcinoma. Oncotarget. 7:16012–16022. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun J, Cheng L, Shi H, Zhang Z, Zhao H,
Wang Z and Zhou M: A potential panel of six-long non-coding RNA
signature to improve survival prediction of diffuse large-B-cell
lymphoma. Sci Rep. 6:278422016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang L, Yi K, Wang H, Zhao Y and Xi M:
Comprehensive analysis of lncRNAs microarray profile and
mRNA-lncRNA co-expression in oncogenic HPV-positive cervical cancer
cell lines. Oncotarget. 7:49917–49929. 2016.PubMed/NCBI
|
|
19
|
Zhou M, Guo M, He D, Wang X, Cui Y, Yang
H, Hao D and Sun J: A potential signature of eight long non-coding
RNAs predicts survival in patients with non-small cell lung cancer.
J Transl Med. 13:2312015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou M, Sun Y, Sun Y, Xu W, Zhang Z, Zhao
H, Zhong Z and Sun J: Comprehensive analysis of lncRNA expression
profiles reveals a novel lncRNA signature to discriminate
nonequivalent outcomes in patients with ovarian cancer. Oncotarget.
7:32433–32448. 2016.PubMed/NCBI
|
|
21
|
Zhou M, Wang X, Shi H, Cheng L, Wang Z,
Zhao H, Yang L and Sun J: Characterization of long non-coding
RNA-associated ceRNA network to reveal potential prognostic lncRNA
biomarkers in human ovarian cancer. Oncotarget. 7:12598–12611.
2016.PubMed/NCBI
|
|
22
|
Keniry A, Oxley D, Monnier P, Kyba M,
Dandolo L, Smits G and Reik W: The H19 lincRNA is a developmental
reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell
Biol. 14:659–665. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cui H, Onyango P, Brandenburg S, Wu Y,
Hsieh CL and Feinberg AP: Loss of imprinting in colorectal cancer
linked to hypomethylation of H19 and IGF2. Cancer Res.
62:6442–6446. 2002.PubMed/NCBI
|
|
24
|
Tsang WP, Ng EK, Ng SS, Jin H, Yu J, Sung
JJ and Kwok TT: Oncofetal H19-derived miR-675 regulates tumor
suppressor RB in human colorectal cancer. Carcinogenesis.
31:350–358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Matouk IJ, DeGroot N, Mezan S, Ayesh S,
Abu-lail R, Hochberg A and Galun E: The H19 non-coding RNA is
essential for human tumor growth. PLoS One. 2:e8452007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ariel I, Miao HQ, Ji XR, Schneider T, Roll
D, de Groot N, Hochberg A and Ayesh S: Imprinted H19 oncofetal RNA
is a candidate tumour marker for hepatocellular carcinoma. Mol
Pathol. 51:21–25. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hibi K, Nakamura H, Hirai A, Fujikake Y,
Kasai Y, Akiyama S, Ito K and Takagi H: Loss of H19 imprinting in
esophageal cancer. Cancer Res. 56:480–482. 1996.PubMed/NCBI
|
|
28
|
Byun HM, Wong HL, Birnstein EA, Wolff EM,
Liang G and Yang AS: Examination of IGF2 and H19 loss of imprinting
in bladder cancer. Cancer Res. 67:10753–10758. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Berteaux N, Lottin S, Monté D, Pinte S,
Quatannens B, Coll J, Hondermarck H, Curgy JJ, Dugimont T and
Adriaenssens E: H19 mRNA-like noncoding RNA promotes breast cancer
cell proliferation through positive control by E2F1. J Biol Chem.
280:29625–29636. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lottin S, Adriaenssens E, Dupressoir T,
Berteaux N, Montpellier C, Coll J, Dugimont T and Curgy JJ:
Overexpression of an ectopic H19 gene enhances the tumorigenic
properties of breast cancer cells. Carcinogenesis. 23:1885–1895.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
McCubrey JA, Steelman LS, Chappell WH,
Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M,
Tafuri A, et al: Roles of the Raf/MEK/ERK pathway in cell growth,
malignant transformation and drug resistance. Biochim Biophys Acta.
1773:1263–1284. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li X, Zhang J, Gao L, McClellan S, Finan
MA, Butler TW, Owen LB, Piazza GA and Xi Y: MiR-181 mediates cell
differentiation by interrupting the Lin28 and let-7 feedback
circuit. Cell Death Differ. 19:378–386. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Khaitan D, Dinger ME, Mazar J, Crawford J,
Smith MA, Mattick JS and Perera RJ: The melanoma-upregulated long
noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer
Res. 71:3852–3862. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Calin GA, Liu CG, Ferracin M, Hyslop T,
Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, et
al: Ultraconserved regions encoding ncRNAs are altered in human
leukemias and carcinomas. Cancer Cell. 12:215–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Braconi C, Valeri N, Kogure T, Gasparini
P, Huang N, Nuovo GJ, Terracciano L, Croce CM and Patel T:
Expression and functional role of a transcribed noncoding RNA with
an ultraconserved element in hepatocellular carcinoma. Proc Natl
Acad Sci USA. 108:786–791. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Matouk IJ, Halle D, Raveh E, Gilon M,
Sorin V and Hochberg A: The role of the oncofetal H19 lncRNA in
tumor metastasis: Orchestrating the EMT-MET decision. Oncotarget.
7:3748–3765. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xia T, Liao Q, Jiang X, Shao Y, Xiao B, Xi
Y and Guo J: Long noncoding RNA associated-competing endogenous
RNAs in gastric cancer. Sci Rep. 4:60882014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang W, Ning N and Jin X: The lncRNA H19
promotes cell proliferation by competitively binding to miR-200a
and derepressing β-catenin expression in colorectal cancer. Biomed
Res Int. 2017:27674842017.PubMed/NCBI
|
|
43
|
Liang WC, Fu WM, Wong CW, Wang Y, Wang WM,
Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF and Waye MM: The lncRNA
H19 promotes epithelial to mesenchymal transition by functioning as
miRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liang W, Zou Y, Qin F, Chen J, Xu J, Huang
S, Chen J and Dai S: sTLR4/MD-2 complex inhibits colorectal cancer
migration and invasiveness in vitro and in vivo by lncRNA H19
down-regulation. Acta Biochim Biophys Sin (Shanghai). 49:1035–1041.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ohtsuka M, Ling H, Ivan C, Pichler M,
Matsushita D, Goblirsch M, Stiegelbauer V, Shigeyasu K, Zhang X,
Chen M, et al: H19 Noncoding RNA, an independent prognostic factor,
regulates essential Rb-E2F and CDK8-β-catenin signaling in
colorectal cancer. EBioMedicine. 13:113–124. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Peyssonnaux C, Provot S,
Felder-Schmittbuhl MP, Calothy G and Eychène A: Induction of
postmitotic neuroretina cell proliferation by distinct Ras
downstream signaling pathways. Mol Cell Biol. 20:7068–7079. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yan J, Roy S, Apolloni A, Lane A and
Hancock JF: Ras isoforms vary in their ability to activate Raf-1
and phosphoinositide 3-kinase. J Biol Chem. 273:24052–24056. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gioeli D, Mandell JW, Petroni GR, Frierson
HF Jr and Weber MJ: Activation of mitogen-activated protein kinase
associated with prostate cancer progression. Cancer Res.
59:279–284. 1999.PubMed/NCBI
|
|
49
|
Abreu-Martin MT, Chari A, Palladino AA,
Craft NA and Sawyers CL: Mitogen-activated protein kinase kinase
kinase 1 activates androgen receptor-dependent transcription and
apoptosis in prostate cancer. Mol Cell Biol. 19:5143–5154. 1999.
View Article : Google Scholar : PubMed/NCBI
|
